Liver Diseases  >>  PPI-461  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
PPI-461 / BioCryst
NCT01247194: A Phase 1b Study of PPI-461 in Patients With HCV Genotype 1

Completed
1b
24
US, Europe
PPI-461, Placebo
Presidio Pharmaceuticals, Inc.
Chronic Genotype 1 Hepatitis C Virus Infection
05/11
06/11

Download Options